corsodyl 2 mg/ml sumute suuonteloon
glaxosmithkline consumer healthcare aps - chlorhexidine gluconate - sumute suuonteloon - 2 mg/ml - klooriheksidiini
panadol forte 1000 mg tabletti, kalvopäällysteinen
haleon denmark aps - paracetamol - tabletti, kalvopäällysteinen - 1000 mg - parasetamoli
lamisil 1 % liuos iholle
glaxosmithkline consumer healthcare aps - terbinafine hydrochloride - liuos iholle - 1 % - terbinafiini
lamisil 1 % sumute iholle, liuos
glaxosmithkline consumer healthcare aps - terbinafine hydrochloride - sumute iholle, liuos - 1 % - terbinafiini
lamisil dermgel 1 % geeli
glaxosmithkline consumer healthcare aps - terbinafine - geeli - 1 % - terbinafiini
lamisil solo 1 % liuos iholle
glaxosmithkline consumer healthcare aps - terbinafine hydrochloride - liuos iholle - 1 % - terbinafiini
panadol coffein 500 mg / 65 mg tabletti, kalvopäällysteinen
haleon denmark aps - caffeine, paracetamol - tabletti, kalvopäällysteinen - 500 mg / 65 mg - parasetamoli
flutide 50 mikrog/annos nenäsumute, suspensio
glaxosmithkline consumer healthcare aps - fluticasoni propionas - nenäsumute, suspensio - 50 mikrog/annos - flutikasoni
lenalidomide krka d.d.
krka, d.d., novo mesto - lenalidomide hydrochloride hydrate - multiple myeloma; lymphoma, follicular; myelodysplastic syndromes - immunosuppressantit - multiple myelomalenalidomide krka d. as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) on tarkoitettu aikuisille potilaille, joilla on aiemmin hoitamaton multippeli myelooma, jotka eivät ole oikeutettuja siirto. lenalidomide krka d. in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka d. as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. follicular lymphomalenalidomide krka d. in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).
androcur 50 mg tabletti
bayer oy - cyproteroni acetas - tabletti - 50 mg - syproteroni